Biochemistry Professor Peter S. Kim, Assistant Professor of Chemical Engineering and Stanford Data Science faculty Brian Hie, and members from Kim Lab co-led research on a new machine learning-based method for designing antibody drugs. The method was shown to improve a once FDA-approved SARS-CoV-2 antibody that had been discontinued due to ineffectiveness.